Cardiovascular disease (CVD) is the major cause of mortality in dialysis patients. Aspirin,
beta‐blockers, statins, and angiotensin‐converting enzyme (ACE) inhibitors reduce CVD …

OBJECTIVE: To investigate the prevalence of and indications for digoxin use and the
prevalence of beta blocker and calcium channel blocker use in older patients with pevious …

New information published since 1992 prompted a critical reevaluation of recommendations
for treatment of arrhythmias with 2 goals:(1) to develop new recommendations for treatment …

OBJECTIVE To provide an evidence-based overview of drug treatment for long-term
secondary prevention of myocardial infarction (MI). DATA SOURCES We conducted …

Background: Statins, beta-blockers, and angiotensin-converting enzyme
inhibitors/angiotensin II receptor blockers have been advocated by guidelines as secondary …

Background A commonly voiced concern is that health maintenance organizations (HMOs)
may withhold or delay the provision of urgent, essential care, especially for vulnerable …

OBJECTIVE To investigate the prevalence of beta blocker use and calcium channel blocker
use in older patients with prior myocardial infarction at the time of admission to a nursing …

OBJECTIVE--To see whether patients taking an oral beta blocker at the time of admission to
hospital with myocardial infarction have a reduced risk of death at 28 days. DESIGN …

Background Randomized controlled trials have demonstrated the efficacy of selected β-
blockers for preventing cardiovascular (CV) events in patients following myocardial …

The long‐acting antianginal drug molsidomine has been shown experimentally to reduce
myocardial infarct size when administered prior to or after cardiac insult. This is due to …